CTL quality and the control of human retroviral infections (Q37543246)

20 August 2017

1 reference

title

CTL quality and the control of human retroviral infections (English)

1 reference

20 August 2017

0 references

Charles R M Bangham

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

European Journal of Immunology

20 August 2017

published in

1 reference

20 August 2017

volume

39

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

1700-1712

1 reference

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

The influence of HLA genotype on AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HIV evolution: CTL escape mutation and reversion after transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Quantifying HTLV-I dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Population dynamics of immune responses to persistent viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

How does HTLV-I persist despite a strong cell-mediated immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Mathematical models of cytotoxic T-lymphocyte killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

The avidity and lytic efficiency of the CTL response to HTLV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

T cell affinity maturation by selective expansion during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

A kinetic basis for T cell receptor repertoire selection during an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Avidity of CD8 T cells sharpens immunodominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

High-avidity CD8+ T cells: optimal soldiers in the war against viruses and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Complete but curtailed T-cell response to very low-affinity antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Cell Surface Structures Involved in T Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Selective induction of high avidity CTL by altering the balance of signals from APC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Vaccines with enhanced costimulation maintain high avidity memory CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

IL-12 enhances CTL synapse formation and induces self-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Enhancing SIV-specific immunity in vivo by PD-1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Regulatory T cells in virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Regulatory T cells in HIV infection: who's suppressing what?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Depletion of regulatory T cells in HIV infection is associated with immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

KIR-HLA intercourse in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

A whole-genome association study of major determinants for host control of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Loss of Viral Control in Early HIV‐1 Infection Is Temporally Associated with Sequential Escape from CD8+T Cell Responses and Decrease in HIV–1–Specific CD4+and CD8+T Cell Frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

Foxp3+ regulatory T cells in antiretroviral-naive HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Elite suppression of HIV-1 replication

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Multiple CTL specificities against autologous HIV-1-infected BLCLs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Emerging challenges in regulatory T cell function and biology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Frequency and function of HIV-specific CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939451

7 January 2021

Identifiers

DOI

10.1002/EJI.200939451

1 reference

release_y5kvsg5rzzgtxnwbdny74jl3mq

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y5kvsg5rzzgtxnwbdny74jl3mq

24 November 2022

mapped directly with Wikidata item

1 reference